| Revenues | | 348.12 | 367.21 | 334.21 | 314.64 |
| | 212.59 | - | - | - |
| Selling, General, and Administrative | | 212.59 | - | - | - |
| Research and Development | | 48.24 | - | - | - |
| Costs And Expenses | | 432.83 | 428.62 | 395.20 | 376.41 |
| Operating Income/Loss | | -84.71 | -61.41 | -61.00 | -61.77 |
| Income/Loss From Equity Method Investments | | -3.09 | -3.15 | 1.52 | -2.10 |
| Income/Loss From Continuing Operations Before Tax | | -122.90 | -57.01 | -81.22 | -40.53 |
| Income Tax Expense/Benefit, Deferred | - | - | -6.45 | - | - |
| Income Tax Expense/Benefit | | -0.06 | -5.99 | 0.28 | 0.21 |
| | -125.92 | -54.17 | -79.98 | -42.84 |
| Attributable To Parent | | -125.92 | -54.17 | -79.98 | -42.84 |
| Basic Average Shares | | 0.18 | 0.00 | 0.17 | 0.17 |
| Diluted Average Shares | | 0.18 | 0.00 | 0.17 | 0.17 |
| Basic Earnings Per Share | | -0.70 | -0.31 | -0.46 | -0.25 |
| Diluted Earnings Per Share | | -0.71 | -0.31 | -0.46 | -0.25 |
TEM
